The global metabolomics market is consolidated, with top five players accounting for 74.7% of the share in 2015. These five companies are Agilent Technologies, ThermoFisher Scientific Inc., Waters Corporation, Shimadzu Corporation, and Bruker Corporation. Most of these companies are also involved in the sale of other research equipment. Since several manufacturers have headquarters in the U.S., North American region yields most the revenue in this market, although Asia Pacific is projected to emerge as a lucrative regional market soon, gaining from investments by established as well as new players.
According to this report, the global metabolomics market had an opportunity of US$602.6 mn in 2015, which is estimated to reach US$2.5 bn by the end of 2024, rising at a robust CAGR of 17.1% during the forecast period of 2016–2024.
Mass Spectrometry Remains In-demand Sub-segment
By technique, the report segments the market on the basis of separation techniques and detection techniques. Separation technique, which accounted for 68.1% of the metabolomics market in 2015, is sub-segmented into gas chromatography (GC), capillary electrophoresis (CE), high performance liquid chromatography (HPLC), and ultra-performance liquid chromatography (UPLC). Collectively, the revenue in the segment of separation techniques is expected to reach a valuation of US$ 1.73 bn by the end of 2024, gaining from factors such as increasing demand for biomarker discovery and personalized medicines. Detection techniques are sub-segmented into nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry. The market for mass spectrometry remains most prominent, estimated to reach a valuation of US$426.1 mn by the end of the forecast period.
Geographically, North America remains the most lucrative region, independently accounting for a revenue of US$264.5 mn in 2015. This dominance is primarily attributed to the increasing demand for personalized medicine and funding for research. However, Asia Pacific is projected the best CAGR during the forecast period, due to the growing demand for metabolomics in Asian countries such as China and Japan. The uniqueness of metabolomics in the Chinese population has led to the demand of new research and development investment from multinationals in Asia and is expected to offer competitive edge to domestic players.
Personalized Medicines Demand Driving Growth
The global market for metabolomics is driven by several factors such as increasing demand for personalized medicines in the developed regions, growing research funding, and government support. The National Institutes of Health (NIH) has recently released five request for application (RFA) in metabolomics field. These RFAs has set aside US$110 mn for the next five years. The RFA’s include regional comprehensive metabolomics resource cores, mentored research scientist award in metabolomics, development of curses or workshops in metabolomics, technology development to enable large scale metabolomics analyses, and metabolomics data repository and coordinating center. Additionally, increased research and development activities across biotechnology and pharmaceutical sectors will escalate demand for metabolomics. However, the dearth of skilled professionals and low rate of adoption, data processing, and analysis are the factors hampering the growth rate.
The author of the report, “To advance the clinical course of diseases, more accurate diagnostic and assessment approaches are required. In order to achieve this, metabolomics, offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional technologies.”
The information presented in this review is based on a Transparency Market Research report, titled, “Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
Key Segments of the Global Metabolomics Market
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453